safety assessment of ceramides as used in cosmetics · safety assessment of ceramides as used in...

Safety Assessment of Ceramides as Used in Cosmetics

Status: Draft Report for Panel Review Release Date: May 16, 2014 Panel Meeting Date: June 9-10, 2014

The 2014 Cosmetic Ingredient Review Expert Panel members are: Chairman, Wilma F. Bergfeld, M.D., F.A.C.P.; Donald V. Belsito, M.D.; Ronald A. Hill, Ph.D.; Curtis D. Klaassen, Ph.D.; Daniel C. Liebler, Ph.D.; James G. Marks, Jr., M.D.; Ronald C. Shank, Ph.D.; Thomas J. Slaga, Ph.D.; and Paul W. Snyder, D.V.M., Ph.D. The CIR Director is Lillian J. Gill, D.P.A. This safety assessment was prepared by Ivan J. Boyer, Ph.D., Senior Toxicologist, Christina L. Burnett, Senior Scientific Analyst/Writer, and Bart Heldreth, Ph.D., Chemist.

© Cosmetic Ingredient Review 1620 L Street, NW, Suite 1200 ◊ Washington, DC 20036-4702 ◊ ph 202.331.0651 ◊fax 202.331.0088

◊ [email protected]

Commitment & Credibility since 1976

Memorandum

To: CIR Expert Panel Members and Liaisons From: Ivan Boyer, Senior Toxicologist Date: May 16, 2014 Subject: Draft Safety Assessment on Ceramides In March 2014, CIR issued a Scientific Literature Review (SLR) Notice to Proceed (SLR Notice) for Ceramides. These ingredients function primarily as hair conditioning agents and skin conditioning agents-miscellaneous. There are a total of 14 ingredients in this safety assessment.

An intensive search of information in the published scientific literature, online databases, and other sources on these ingredients provided insufficient information to justify preparation of a formal SLR. These searches identified efficacy studies on some of the named cosmetic ingredients, efficacy studies of other cosmetic ingredients or pharmaceuticals in which naturally-occurring ceramide levels in the skin were evaluated, or data on a pseudo-ceramides (such as that found in an approved medical device to serve a skin “barrier repair” function) that are not cosmetic ingredients. These studies were deemed not relevant for the assessment of safety for the use of ceramide ingredients in cosmetics. Thus, CIR issued the SLR Notice to alert interested parties that a safety assessment is being prepared and to request information in multiple areas, including:

• Impurities data • Toxicokinetics data, especially dermal absorption • If these ingredients exhibit appreciable dermal absorption, then oral animal toxicity data, including:

o Reproductive/developmental toxicity (DART) data o Carcinogenicity data o Genotoxicity data

• If these ingredients have no appreciable dermal penetration, DART, genotoxicity, and carcinogenicity data may not be crucial, but would strengthen the safety assessment

• Oral, inhalation, and dermal toxicity data • Dermal, ocular, and/or other mucous membrane irritation and sensitization data • Other relevant safety information that may be available

Concentration of use data that were provided by the Personal Care Products Council (Council) have been received and incorporated into the report. No unpublished data or comments were received.

According to the FDA’s VCRP database, ceramide 3 has the most reported uses in cosmetic and personal care products, with a total of 359; the majority of the uses is in leave-on skin care preparations. Ceramide 2 has the second greatest

mailto:[email protected]

http://www.cir-safety.org/

number of overall uses reported, with a total of 110; the majority of those uses is also in leave-on skin care preparations. In the Council’s survey of use concentrations, ceramide 3 had a highest maximum use concentration range of 1.0 x 10-8% to 0.2% with 0.2 % reported in lipstick and face and neck skin care preparations. Ceramide 2 had a highest maximum use concentration range of 5 x 10-6% to 0.2%, with 0.2% reported in eye lotion and face and neck skin care preparations. Most of the other use concentrations that were reported had similar ranges. Ceramide 1A was not reported in the VCRP, but the industry survey indicated use in leave-on formulations at up to 0.01%. It should be presumed that ceramide 1A is used in at least one cosmetic formulation.

The Panel should consider the lack of information available on which to base a safety assessment of these ingredients, and specify the data needed to complete the assessment.

mailto:[email protected]

http://www.cir-safety.org/

Distributed for Comment Only -- Do Not Cite or Quote

Ceramides History March 2014 – Scientific Literature Review Notice announced.


Ceramides Data Profile – June 2014 – Writers, Ivan Boyer, Christina Burnett and Bart Heldreth

In-U

se

Phys

ical

/Che

mic

al

Prop

ertie

s

Met

hod

of

Man

ufac

turi

ng

Com

posi

tion

Toci

koki

neti

cs

Acu

te T

oxic

ity

Repe

ated

Dos

e To

xici

ty

Repr

o. /

Dev

elop

. To

xici

ty

Geno

toxi

city

Car

cino

geni

city

Irri

tatio

n/Se

nsiti

zatio

n - A

nim

al

Irri

tatio

n/Se

nsiti

zatio

n - C

linic

al

Ocu

lar/

Muc

osal

Phot

otox

icity

Cas

e St

udie

s

Ceramide 1 X

Ceramide 1A X

Ceramide 2 X

Ceramide 3 X

Ceramide 4

Ceramide 5

Ceramide 6 II X

Ceramide AP X

Ceramide AS

Ceramide EOP X

Ceramide EOS X

Ceramide NP X

Ceramide NS X Ceramide NS Dilaurate

“X” indicates that data were available in the category for that ingredient. Shaded cells indicate ingredients that have been previously reviewed by CIR.


Search Strategy for Ceramide Ingredients

• PubMed – February 18, 2014 o Search for “ceramide dermal sensitization” – 1 hit, 1 ordered o Search for “ceramide dermal irritation” – 0 hits

• SciFinder – February 19, 2014 o Search for “ceramides toxicity review. – 106 hits, 31 ordered

• SciFinder – February 21, 2014 o Search ceramides by name/CAS#, limited search by document type, adverse effects – 184 hits, 24 ordered

• From reading review papers ordered – March 11, 2014 o Search for potentially relevant citations – 24 selected, 24 ordered

• SciFinder – March 12, 2014 o Search for “ceramides safety” – 29 hits, 1 obtained

Online Info

• COSMOS Database – March 12, 2014 o Search for “ceramide” or “ceramides” studies/data – 0 hits

• European Chemicals Agency (ECHA) Database – March 12, 2014 o Search for INCI names and available CASNs, and “ceramide” – 0 hits

• Internet (Google Search Engine) – March 12, 2014 o Search for “ceramides medical devices” – 1 potentially relevant hit, downloaded

• eChemPortal (OECD) – March 12, 2014 o Search for studies/data on “ceramides” – 0 hits

• INCI Dictionary/Cosmetics InfoBase – March 12, 2014 o Search for studies/data on “ceramide” or “ceramides” – 0 hits

• U.S. EPA HPV List and ToxRef DB – March 12, 2014 o Search for studies/data on “ceramide” or “ceramides” – 0 hits

• eCFR – March 12, 2014 o Search for Code of Federal Regulations (CFR) notices – 1 hit, downloaded

• National Toxicology Program (NTP) Database – April 24, 2014 o Search for studies on “ceramide”(all or part of chemical name) – 0 hits

• SCCS/SCCP – April 24, 2014 o Search for “ceramide” – 0 hits

• Sigma Aldrich – April 24, 2014 o Search for “ceramide” MSDSs – 0 hits

• National Library of Medicine (NLN) ToxNet Hazardous Substance Data Bank – April 24, 2014 o Search for “ceramide” – 0 relevant hits

• Internet (Google Search Engine) – April 24, 2014 o Search for “ceramide 4,” “ceramide 5,” “ceramide AS,” and “ceramide NS”– 0 relevant hits


Safety Assessment of Ceramides as Used in Cosmetics

Status: Draft Report for Panel Review Release Date: May 16, 2014 Panel Meeting Date: June 9-10, 2014

The 2014 Cosmetic Ingredient Review Expert Panel members are: Chairman, Wilma F. Bergfeld, M.D., F.A.C.P.; Donald V. Belsito, M.D.; Ronald A. Hill, Ph.D.; Curtis D. Klaassen, Ph.D.; Daniel C. Liebler, Ph.D.; James G. Marks, Jr., M.D.; Ronald C. Shank, Ph.D.; Thomas J. Slaga, Ph.D.; and Paul W. Snyder, D.V.M., Ph.D. The CIR Director is Lillian J. Gill, D.P.A. This safety assessment was prepared by Ivan J. Boyer, Ph.D., Senior Toxicologist, Christina L. Burnett, Senior Scientific Analyst/Writer, and Bart Heldreth, Ph.D., Chemist.

© Cosmetic Ingredient Review 1620 L Street, NW, Suite 1200 ◊ Washington, DC 20036-4702 ◊ ph 202.331.0651 ◊fax 202.331.0088

◊ [email protected]


INTRODUCTION Ceramide ingredients function primarily as hair conditioning agents and skin conditioning agents-

miscellaneous in cosmetics.1 The full list of ingredients reviewed in this safety assessment is described in Table 1. Many of the reports found in the published literature presented efficacy studies on the named cosmetic

ingredients, efficacy studies of other cosmetic ingredients or pharmaceuticals in which naturally-occurring ceramide levels in the skin were evaluated, and data on pseudo-ceramides (such as that found in an approved medical device), which are not a cosmetic ingredients. These studies were not relevant to the assessment of safety of the use of the ceramide ingredients in cosmetics.

An intensive search of the scientific literature, databases, and other information sources on these ingredients provided insufficient relevant information to justify the preparation of a formal Scientific Literature Review (SLR). The Cosmetic Ingredient Review (CIR), therefore, issued a SLR Notice to Proceed in March 2014 to alert interested parties that a safety assessment was being prepared. CIR sought information in a wide range of areas, including:

• Impurities data; • Toxicokinetics data, specifically dermal absorption; if these ingredients were to have appreciable

dermal absorption, oral animal toxicity data, including reproductive/developmental toxicity and carcinogenicity data, are needed, as are genotoxicity data; these data may not be crucial if these ingredients have no appreciable dermal penetration, however, if they were available, they would improve the resulting safety assessment;

• Oral, inhalation, and/or dermal toxicity data; • Dermal, ocular, and/or other mucous membrane irritation and sensitization data; and • Any other relevant safety information that may be available.

CHEMISTRY

Generally, a ceramide is the amidation reaction product of a sphingoid base and a fatty acid.

a sphingoid base (when m is 1 this is sphingosine)

HO

NH2

OH

CH3m

HO CH3

O a fatty acidn

HO

HN

OH

CH3m

CH3

O

n

amidation

example of a ceramide

Figure 1. Example of a ceramide structure

The ingredients described herein vary principally in the chain lengths of both the sphingoid and fatty acid residues, and in the degree of unsaturation in those chains. Additionally, each of these ingredients is a mixture of ceramides, described in more detail in Table 1.

In biological systems, ceramides are synthesized by de novo synthesis, sphingomyelin hydrolysis, or through a salvage pathway.2 Ceramide manufacture could be accomplished by a variety of synthetic methods, but most methods involve amidation of a fatty acid with a sphingoid base.3 This can be accomplished by reaction of the


sphingoid base with an acyl chloride, but the results are not selective and esterification and amidation occur concurrently. However, mild alkaline hydrolysis can selectively remove the esters. Alternatively, activating the fatty acid with a carbodiimide enables ceramide synthesis without esterification.

USE Cosmetic

Table 2 presents the current product-formulation use data for ceramide ingredients. These ingredients function primarily as hair conditioning agents and skin conditioning agents-miscellaneous.1

According to information supplied to the Food and Drug Administration (FDA) by industry as part of the Voluntary Cosmetic Registration Program (VCRP), ceramide 3 has the most reported uses in cosmetic and personal care products, with a total of 359; the majority of the uses are in leave-on skin care preparations.4 Ceramide 2 has the second greatest number of overall uses reported, with a total of 110; the majority of those uses are also in leave-on skin care preparations.

In the Personal Care Products Council’s use concentration survey, ceramide 3 had a maximum-use concentration range of 1.0 x 10-8% to 0.2%, with 0.2% reported in lipstick and face and neck skin care preparations.5 Ceramide 2 had a maximum-use concentration range of 5 x 10-6% to 0.2%, with 0.2% reported in eye lotion and face and neck skin care preparations. Most of the other use concentrations that were reported had similar ranges.

In some cases, no reported uses were received from the VCRP, but a maximum-use concentration was provided in the industry survey. For example, ceramide 1A was not reported in the VCRP database to be in use, but the industry survey indicated that it is used in leave-on formulations at up to 0.01%. It should be presumed that ceramide 1A is used in at least one cosmetic formulation.

Ceramide 4, ceramide 5, ceramide AS, and ceramide NS dilaurate were indicated not to be in use based on the VCRP data and the results of the Council concentration of use survey.

Some of these ingredients were reported to be used in hair sprays and body and hand or moisturizing sprays and could possibly be inhaled. For example, ceramide 3 was reported to be used in body and hand sprays at a maximum concentration of 1.0 x 10-3%. In practice, 95% to 99% of the droplets/particles released from cosmetic sprays have aerodynamic equivalent diameters >10 µm, with propellant sprays yielding a greater fraction of droplets/particles below 10 µm compared with pump sprays.6-9 Therefore, most droplets/particles incidentally inhaled from cosmetic sprays would be deposited in the nasopharyngeal and bronchial regions and would not be respirable (i.e., they would not enter the lungs) to any appreciable amount.7,8

TOXICOKINETICS

Data on the absorption, distribution, metabolism, and excretion of ceramides were not found in the published literature, nor were unpublished data provided.

TOXICOLOGICAL STUDIES Data on acute and repeated dose toxicity of ceramides were not found in the published literature, nor were unpublished data provided.

REPRODUCTIVE AND DEVELOPMENTAL TOXICITY Data on reproductive and developmental toxicity of ceramides were not found in the published literature, nor were unpublished data provided.

GENOTOXICITY Data on genotoxicity of ceramides were not found in the published literature, nor were unpublished data provided.

CARCINOGENICITY Data on carcinogenicity of ceramides were not found in the published literature, nor were unpublished data provided.

IRRITATION AND SENSITIZATION Data on irritation and sensitization of ceramides were not found in the published literature, nor were unpublished data provided.


SUMMARY The ceramide ingredients function as hair conditioning agents and skin conditioning agents-miscellaneous

in cosmetics. According to information supplied to FDA, ceramide 3 has the most reported uses in cosmetic and personal care products, with a total of 359; the majority of the uses are in leave-on skin care preparations. Ceramide 2 has the second greatest number of overall uses reported, with a total of 110; the majority of those uses are also in leave-on skin care preparations. In the Personal Care Products Council’s use concentration survey, ceramide 3 had a maximum-use concentration range of 1.0 x 10-8% to 0.2%, with 0.2% reported in lipstick and face and neck skin care preparations. Ceramide 2 had a maximum-use concentration range of 5 x 10-6% to 0.2%, with 0.2% reported in eye lotion and face and neck skin care preparations. Most of the other use concentrations that were reported had similar ranges.

Data on the toxicokinetics, acute and repeated dose toxicity, genotoxicity, carcinogenicity, reproductive and developmental toxicity, or irritation and sensitization of ceramides were not found in the published literature.


TABLES AND FIGURES

Table 1. Definitions and idealized structures of the ingredients in this safety assessment.1

Ingredient CAS No. Definition / Structure

Ceramide 1 100403-19-8

Ceramide 1 is the N-acylated phytosphingosine having the erythro structure that conforms generally to the formula:

where n has a value ranging from 10 to 20.

Ceramide 1A 100403-19-8

Ceramide 1 A is the N-acylated phytosphingosine having the erythro structure that conforms generally to the formula:

where n has a value ranging from 10 to 20.

Ceramide 2 100403-19-8

Ceramide 2 is the N-acylated sphingolipid having the erythro structure that conforms generally to the formulas:

where m has a value ranging from 14 to 28 and n has a value ranging from 10 to 16.




Ceramide 3 100403-19-8 72968-43-5

Ceramide 3 is the N-acylated phytosphingosine having the erythro structure that conforms generally to the formula:

where m has a value ranging from 12 to 28 in which the acyl moiety may be saturated, mono-unsaturated, or di-unsaturated and n has a value ranging from 10 to 20.

Ceramide 4 100403-19-8

Ceramide 4 is the N-acylated sphingolipid having the erythro structure that conforms generally to the formula:

where m has a value ranging from 13 to 27 in which the acyl moiety may be saturated or mono-unsataurated and n has a value ranging from 10 to 16. Ceramide 4 is similar to Ceramide 5, however, the acylating hydroxy acids are generally shorter in Ceramide 4 than in Ceramide 5.

Ceramide 5 100403-19-8

Ceramide 5 is the N-acylated sphingolipid having the erythro structure that conforms generally to the formula:

where m has a value ranging from 13 to 27 in which the acyl moiety may be saturated or mono-unsaturated and n has a value ranging from 10 to 16. Ceramide 5 is similar to Ceramide 4, however, the acylating hydroxy acids are generally longer in Ceramide 5 than in Ceramide 4.

Ceramide 6 II 100403-19-8

Ceramide 6 II is the N-acylated phytosphingosine having the erythro structure that conforms generally to the formula:

where m has a value ranging from 13 to 27 and n has a value ranging from 12 to 20.

Ceramide AP Ceramide AP is the N-acylated sphingolipid consisting of Phytosphingosine having the D-erythro structure linked to an alpha-hydroxy saturated or unsaturated fatty acid.

Ceramide AS Ceramide AS is the N-acylated sphingolipid consisting of sphingosine having the D-erythro structure linked to an alpha-hydroxy saturated or unsaturated fatty acid.

Ceramide EOP Ceramide EOP is the N-acylated sphingolipid consisting of Phytosphingosine having the D-erythro structure linked to an esterified omega-hydroxy saturated or unsaturated fatty acid.




Ceramide EOS Ceramide EOS is the N-acylated sphingolipid consisting of sphingosine having the D-erythro structure linked to an esterified omega-hydroxy saturated or unsaturated fatty acid.

Ceramide NP Ceramide NP is the N-acylated sphingolipid consisting of Phytosphingosine having the D-erythro structure linked to normal saturated or unsaturated fatty acid.

Ceramide NS Ceramide NS is the N-acylated sphingolipid consisting of sphingosine having the D-erythro structure linked to a normal saturated or unsaturated fatty acid.

Ceramide NS Dilaurate Ceramide NS Dilaurate is the diester of Ceramide NS and lauric acid.


Table 2. Frequency (2014) and concentration of use (2013) according to duration and type of exposure for ceramide ingredients.4,5

# of Uses Max Conc of Use (%) # of Uses Max Conc of Use (%) # of Uses Max Conc of Use (%) # of Uses Max Conc of Use (%)

Ceramide 1 Ceramide 2 Ceramide 3 Ceramide 1A Totals1 54 0.0000005-0.1 110 0.000005-0.2 359 0.00000001-0.2 NR 0.01 Duration of Use Leave-On 48 0.0000005-0.1 99 0.000005-0.2 298 0.00000001-0.2 NR 0.01 Rinse Off 6 0.00001-0.00065 11 0.0001-0.1b 61 0.000001-0.013 NR NR Diluted for (Bath) Use NR NR NR NR NR NR NR NR Exposure Type Eye Area 8 0.00002-0.00005 30 0.000005-0.2 29 0.002-0.05 NR 0.01 Incidental Ingestion 4 0.001 9 0.018-0.064 48 0.01-0.2 NR NR Incidental Inhalation-Spray?2,6 25 NR 42 0.01 174 NR NR NR Reported Spray3 NR 0.00065a NR 0.0001c NR 0.00000001-0.001d NR NR Incidental Inhalation-Powder?4,6 25 0.0001 41 0.01 161 0.0001-0.01 NR NR Reported Powder5 NR NR NR NR NR NR NR NR Dermal Contact 47 0.0000005-0.045 86 0.000005-0.2 259 0.00005-0.2 NR 0.01 Deodorant (underarm)-Spray?2 NR NR NR NR NR NR NR NR Reported Spray3 NR NR NR NR NR NR NR NR Reported as Not Spray3 NR NR NR NR NR NR NR NR Hair - Non-Coloring NR 0.000325-0.00065 10 0.0001-0.01 48 0.00000001-0.013 NR NR Hair-Coloring NR NR NR NR NR NR NR NR Nail NR 0.1 NR 0.0004 NR NR NR NR Mucous Membrane 4 0.001 9 0.018-0.064 55 0.01-0.2 NR NR Baby Products NR NR NR NR 3 NR NR NR Ceramide AP Ceramide EOP Ceramide EOS Ceramide 6 II Totals1 14 0.00005-0.2 14 0.000001-0.01 14 0.01 52 0.00003-0.2 Duration of Use Leave-On 14 0.00005-0.2 14 0.000001-0.01 14 0.01 48 0.00003-0.2 Rinse Off NR 0.0005 NR 0.00001 NR NR 4 0.0001-0.00065 Diluted for (Bath) Use NR NR NR NR NR NR NR NR Exposure Type Eye Area 1 0.0025-0.01 1 0.00005-0.01 1 NR 8 0.0025-0.01 Incidental Ingestion NR 0.01 NR 0.001 NR NR 4 0.01 Incidental Inhalation-Spray?2,6 13 NR 13 NR 13 NR 24 NR Reported Spray3 NR NR NR 0.01e NR 0.01f NR 0.00003-0.00065g

Incidental Inhalation-Powder?4,6 13 0.01 13 0.0001 13 NR 24 0.01 Reported Powder5 NR NR NR NR NR NR NR NR Dermal Contact 14 0.00005-0.2 14 0.000001-0.01 14 0.01 46 0.00003-0.2 Deodorant (underarm)-Spray?2 NR NR NR NR NR NR NR NR Reported Spray3 NR NR NR NR NR NR NR NR Reported as Not Spray3 NR NR NR NR NR NR NR NR Hair - Non-Coloring NR NR NR NR NR NR NR 0.00033-0.00065 Hair-Coloring NR NR NR NR NR NR NR NR Nail NR NR NR NR NR NR NR NR Mucous Membrane NR 0.01 NR 0.001 NR NR 4 0.01 Baby Products NR NR NR NR NR NR NR NR


Table 2. Frequency (2014) and concentration of use (2013) according to duration and type of exposure for ceramide ingredients.4,5

# of Uses Max Conc of Use (%) # of Uses Max Conc of Use (%) # of Uses Max Conc of Use (%) # of Uses Max Conc of Use (%)

Ceramide NP Ceramide NS Totals1 16 0.00005-0.2 14 0.001-0.006 Duration of Use Leave-On 16 0.00005-0.2 14 0.001-0.006 Rinse Off NR 0.0005-0.01 NR 0.001 Diluted for (Bath) Use NR 0.001 NR NR Exposure Type Eye Area 2 0.0025-0.005 1 NR Incidental Ingestion NR 0.2 NR NR Incidental Inhalation-Spray?2,6 13 NR 13 NR Reported Spray3 NR NR NR NR Incidental Inhalation-Powder?4,6 13 0.01 13 NR Reported Powder5 NR NR NR NR Dermal Contact 16 0.00005-0.1 14 0.001-0.006 Deodorant (underarm)-Spray?2 NR NR NR NR Reported Spray3 NR NR NR NR Reported as Not Spray3 NR NR NR NR Hair - Non-Coloring NR NR NR NR Hair-Coloring NR NR NR NR Nail NR NR NR NR Mucous Membrane NR 0.001-0.2 NR NR Baby Products 1 NR NR NR

NR = Not reported. 1. Because each ingredient may be used in cosmetics with multiple exposure types, the sum of all exposure types may not equal the sum of total uses. 2. It is possible these products may be sprays, but it is not specified whether the reported uses are sprays. 3. Use in a spray product has been reported in response to a survey conducted by the Council. 4. It is possible these products may be powders, but it is not specified whether the reported uses are powders. 5. Use in a powder product has been reported in response to a survey conducted by the Council. 6. Not specified whether a powder or a spray, so this information is captured for both categories of incidental inhalation. a. 0.00065% in an aerosol hair spray. b. 0.1% in a rinse-off “other” skin care preparation. c. 0.0001% in a spray tonic, dressing, or other hair grooming aid. d. 0.00000001%-0.00065% in an aerosol hair spray; 0.000001% in a pump hair spray; 0.0001% in a spray tonic, dressing, or other hair grooming aid; 0.001% in a body and hand spray; 0.0005% in a

moisturizing pump spray. e. 0.01% in a face and neck spray. f. 0.01% in a face and neck spray. g. 0.00065% in an aerosol hair spray; 0.00003% in a pump spray.


REFERENCES 1. Nikitakis J and Breslawec H. International Cosmetic Ingredient Dictionary and Handbook. 15th ed. Washington, DC:

Personal Care Products Council, 2014.

2. Elkhayat ES, Mohamed GA, and Ibrahim SRM. Activity and structure elucidation of ceramides. Curr Bioact Compd. 2012;8:370-409.

3. Hammarstrõm S. A convenient procedure for the synthesis of ceramides. J Lipid Res. 1971;12:760-765.

4. Food and Drug Administration (FDA). Frequency of use of cosmetic ingredients. FDA Database. 2014. Dated Feb 25.

5. Personal Care Products Council. 11-4-2013. Concentration of Use by FDA Product Category: Ceramides. Unpublished data submitted by Personal Care Products Council. 7 pages.

6. Rothe H, Fautz R, Gerber E, Neumann L, Rettinger K, Schuh W, and Gronewold C. Special aspects of cosmetic spray safety evaluations: Principles on inhalation risk assessment. Toxicol Lett. 2011;205(2):97-104.

7. Rothe H. Special Aspects of Cosmetic Spray Evalulation. 9-26-2011. Unpublished data presented at the 26 September CIR Expert Panel meeting. Washington, D.C.

8. Bremmer HJ, Prud'homme de Lodder LCH, and Engelen JGM. Cosmetics Fact Sheet: To assess the risks for the consumer; Updated version for ConsExpo 4. 2006. Report No. RIVM 320104001/2006. pp. 1-77.

9. Johnsen MA. The Influence of Particle Size. Spray Technology and Marketing. 2004;14(11):24-27.


2014 FDA VCRP Raw Data 03D - Eye Lotion CERAMIDE 1 5 03F - Mascara CERAMIDE 1 3 07C - Foundations CERAMIDE 1 3 07E - Lipstick CERAMIDE 1 4 07G - Rouges CERAMIDE 1 1 07I - Other Makeup Preparations CERAMIDE 1 2 11A - Aftershave Lotion CERAMIDE 1 1 11G - Other Shaving Preparation Products

CERAMIDE 1 2

12A - Cleansing CERAMIDE 1 2 12C - Face and Neck (exc shave) CERAMIDE 1 7 12D - Body and Hand (exc shave) CERAMIDE 1 5 12F - Moisturizing CERAMIDE 1 6 12G - Night CERAMIDE 1 7 12H - Paste Masks (mud packs) CERAMIDE 1 2 12J - Other Skin Care Preps CERAMIDE 1 4 03A - Eyebrow Pencil CERAMIDE 2 1 03B - Eyeliner CERAMIDE 2 1 03C - Eye Shadow CERAMIDE 2 4 03D - Eye Lotion CERAMIDE 2 11 03F - Mascara CERAMIDE 2 5 03G - Other Eye Makeup Preparations

CERAMIDE 2 8

05A - Hair Conditioner CERAMIDE 2 1 05F - Shampoos (non-coloring) CERAMIDE 2 7 05G - Tonics, Dressings, and Other Hair Grooming Aids

CERAMIDE 2 2

07A - Blushers (all types) CERAMIDE 2 1 07B - Face Powders CERAMIDE 2 1 07C - Foundations CERAMIDE 2 5 07E - Lipstick CERAMIDE 2 9 07I - Other Makeup Preparations CERAMIDE 2 9 12A - Cleansing CERAMIDE 2 2 12C - Face and Neck (exc shave) CERAMIDE 2 12 12F - Moisturizing CERAMIDE 2 21 12G - Night CERAMIDE 2 7 12H - Paste Masks (mud packs) CERAMIDE 2 1 12J - Other Skin Care Preps CERAMIDE 2 2 01B - Baby Lotions, Oils, Powders, and Creams

CERAMIDE 3 2

01C - Other Baby Products CERAMIDE 3 1 03B - Eyeliner CERAMIDE 3 1 03C - Eye Shadow CERAMIDE 3 6 03D - Eye Lotion CERAMIDE 3 8 03F - Mascara CERAMIDE 3 4 03G - Other Eye Makeup Preparations

CERAMIDE 3 10

04E - Other Fragrance Preparation CERAMIDE 3 1 05A - Hair Conditioner CERAMIDE 3 15


05B - Hair Spray (aerosol fixatives)

CERAMIDE 3 1

05E - Rinses (non-coloring) CERAMIDE 3 2 05F - Shampoos (non-coloring) CERAMIDE 3 15 05G - Tonics, Dressings, and Other Hair Grooming Aids

CERAMIDE 3 11

05I - Other Hair Preparations CERAMIDE 3 4 07B - Face Powders CERAMIDE 3 2 07C - Foundations CERAMIDE 3 14 07E - Lipstick CERAMIDE 3 48 07G - Rouges CERAMIDE 3 1 07I - Other Makeup Preparations CERAMIDE 3 8 10A - Bath Soaps and Detergents CERAMIDE 3 3 10E - Other Personal Cleanliness Products

CERAMIDE 3 4

11A - Aftershave Lotion CERAMIDE 3 1 11E - Shaving Cream CERAMIDE 3 2 11G - Other Shaving Preparation Products

CERAMIDE 3 2

12A - Cleansing CERAMIDE 3 12 12C - Face and Neck (exc shave) CERAMIDE 3 50 12D - Body and Hand (exc shave) CERAMIDE 3 13 12F - Moisturizing CERAMIDE 3 69 12G - Night CERAMIDE 3 22 12H - Paste Masks (mud packs) CERAMIDE 3 6 12I - Skin Fresheners CERAMIDE 3 3 12J - Other Skin Care Preps CERAMIDE 3 14 13A - Suntan Gels, Creams, and Liquids

CERAMIDE 3 4

03D - Eye Lotion CERAMIDE 6 II 6 03F - Mascara CERAMIDE 6 II 2 07C - Foundations CERAMIDE 6 II 3 07E - Lipstick CERAMIDE 6 II 4 07G - Rouges CERAMIDE 6 II 1 07I - Other Makeup Preparations CERAMIDE 6 II 2 11A - Aftershave Lotion CERAMIDE 6 II 1 11G - Other Shaving Preparation Products

CERAMIDE 6 II 2

12A - Cleansing CERAMIDE 6 II 1 12C - Face and Neck (exc shave) CERAMIDE 6 II 9 12D - Body and Hand (exc shave) CERAMIDE 6 II 3 12F - Moisturizing CERAMIDE 6 II 5 12G - Night CERAMIDE 6 II 7 12H - Paste Masks (mud packs) CERAMIDE 6 II 1 12J - Other Skin Care Preps CERAMIDE 6 II 5 03D - Eye Lotion CERAMIDE AP 1 12C - Face and Neck (exc shave) CERAMIDE AP 11 12F - Moisturizing CERAMIDE AP 1 12G - Night CERAMIDE AP 1 03D - Eye Lotion CERAMIDE EOP 1


12C - Face and Neck (exc shave) CERAMIDE EOP 11 12F - Moisturizing CERAMIDE EOP 1 12G - Night CERAMIDE EOP 1 03D - Eye Lotion CERAMIDE EOS 1 12C - Face and Neck (exc shave) CERAMIDE EOS 11 12F - Moisturizing CERAMIDE EOS 1 12G - Night CERAMIDE EOS 1 01C - Other Baby Products CERAMIDE NP 1 03D - Eye Lotion CERAMIDE NP 2 12C - Face and Neck (exc shave) CERAMIDE NP 11 12F - Moisturizing CERAMIDE NP 1 12G - Night CERAMIDE NP 1 03D - Eye Lotion CERAMIDE NS 1 12C - Face and Neck (exc shave) CERAMIDE NS 11 12F - Moisturizing CERAMIDE NS 1 12G - Night CERAMIDE NS 1


Personal Care

TO: Lillian Gill, Ph.D.

Products Council Committed to Safety, Quality & Innovation

Director- COSMETIC INGREDIENT REVIEW (CIR)

FROM: Halyna Breslawec, Ph.D. Industry Liaison to the CIR Expert Panel

DATE: November 4, 2013

SUB.JECT: Concentration of Use by FDA Product Category: Ceramides

110117th Street, N.W., Suite 3001 Washington, D.C. 20036-47021202.331.1770 1202.331.1969 (fax) I www.personalc:arec:oundl.arg


safety assessment of ceramides as used in cosmetics · safety assessment of ceramides as used in...

Documents